{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:24:25Z","timestamp":1791825865956,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K07CA221931"],"award-info":[{"award-number":["K07CA221931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health,United States","award":["R25CA102618"],"award-info":[{"award-number":["R25CA102618"]}]},{"name":"National Institutes of Health,United States","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}]},{"name":"National Institutes of Health,United States","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}]},{"name":"National Institutes of Health,United States","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00520-024-08855-y","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T23:32:19Z","timestamp":1726875139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-9986","authenticated-orcid":false,"given":"Ian R.","family":"Kleckner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thushini","family":"Manuweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber S.","family":"Kleckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Gewandter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Culakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina E.","family":"Tivarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish A.","family":"Mohile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelli R.","family":"Kesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Mustian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"12","key":"8855_CR1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461\u20132470","journal-title":"Pain"},{"issue":"6","key":"8855_CR2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP et al (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772\u2013781","journal-title":"Ann Neurol"},{"issue":"7","key":"8855_CR3","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00520-013-1766-y","volume":"21","author":"JS Gewandter","year":"2013","unstructured":"Gewandter JS et al (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer 21(7):2059\u20132066","journal-title":"Support Care Cancer"},{"issue":"28","key":"8855_CR4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38(28):3325\u20133348","journal-title":"J Clin Oncol"},{"issue":"18","key":"8855_CR5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941\u20131967","journal-title":"J Clin Oncol"},{"issue":"10","key":"8855_CR6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306\u20131319","journal-title":"Ann Oncol"},{"key":"8855_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.06.013","volume":"205","author":"A Tham","year":"2016","unstructured":"Tham A et al (2016) Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder - a systematic review and a meta-analysis. J Affect Disord 205:1\u201312","journal-title":"J Affect Disord"},{"issue":"6","key":"8855_CR8","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00520-019-05063-x","volume":"28","author":"JS Gewandter","year":"2020","unstructured":"Gewandter JS et al (2020) Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. Support Care Cancer 28(6):2553\u20132562","journal-title":"Support Care Cancer"},{"issue":"6","key":"8855_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jnci\/djz011","volume":"111","author":"SG Dorsey","year":"2019","unstructured":"Dorsey SG et al (2019) The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst 111(6):531\u2013537","journal-title":"J Natl Cancer Inst"},{"key":"8855_CR10","doi-asserted-by":"crossref","first-page":"103575","DOI":"10.1016\/j.critrevonc.2021.103575","volume":"171","author":"S Tamburin","year":"2022","unstructured":"Tamburin S et al (2022) Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. Crit Rev Oncol Hematol 171:103575","journal-title":"Crit Rev Oncol Hematol"},{"key":"8855_CR11","first-page":"183","volume-title":"Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy","author":"IR Kleckner","year":"2021","unstructured":"Kleckner IR et al (2021) Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy. Management and Emerging Strategies for Chemotherapy-Induced Neuropathy, Diagnosis, pp 183\u2013241"},{"issue":"24","key":"8855_CR12","doi-asserted-by":"crossref","first-page":"22278","DOI":"10.1002\/cam4.6753","volume":"12","author":"KM Sturgeon","year":"2023","unstructured":"Sturgeon KM et al (2023) Updated systematic review of the effects of exercise on understudied health outcomes in cancer survivors. Cancer Med 12(24):22278\u201322292","journal-title":"Cancer Med"},{"issue":"4","key":"8855_CR13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00520-017-4013-0","volume":"26","author":"IR Kleckner","year":"2018","unstructured":"Kleckner IR et al (2018) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 26(4):1019\u20131028","journal-title":"Support Care Cancer"},{"key":"8855_CR14","doi-asserted-by":"crossref","first-page":"693133","DOI":"10.3389\/fmolb.2021.693133","volume":"8","author":"M Omran","year":"2021","unstructured":"Omran M et al (2021) Review of the role of the brain in chemotherapy-induced peripheral neuropathy. Front Mol Biosci 8:693133","journal-title":"Front Mol Biosci"},{"key":"8855_CR15","doi-asserted-by":"crossref","first-page":"114803","DOI":"10.1016\/j.bbr.2023.114803","volume":"460","author":"T Manuweera","year":"2024","unstructured":"Manuweera T et al (2024) Preliminary evaluation of novel bodily attention task to assess the role of the brain in chemotherapy-induced peripheral neurotoxicity (CIPN). Behav Brain Res 460:114803","journal-title":"Behav Brain Res"},{"issue":"5","key":"8855_CR16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/cancers14051224","volume":"14","author":"KH Chung","year":"2022","unstructured":"Chung KH et al (2022) Mechanisms, mediators, and moderators of the effects of exercise on chemotherapy-induced peripheral neuropathy. Cancers (Basel) 14(5):1224","journal-title":"Cancers (Basel)"},{"key":"8855_CR17","doi-asserted-by":"publisher","unstructured":"Kleckner IR et al (2017) Evidence for a large-scale brain system supporting allostasis and interoception in humans. Nat Human Behav. 1. https:\/\/doi.org\/10.1038\/s41562-017-0069","DOI":"10.1038\/s41562-017-0069"},{"issue":"9","key":"8855_CR18","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1523\/JNEUROSCI.5587-06.2007","volume":"27","author":"WW Seeley","year":"2007","unstructured":"Seeley WW et al (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27(9):2349\u20132356","journal-title":"J Neurosci"},{"key":"8855_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","volume":"38","author":"ME Raichle","year":"2015","unstructured":"Raichle ME (2015) The brain\u2019s default mode network. Annu Rev Neurosci 38:433\u2013447","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"8855_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2017.06.021","volume":"95","author":"JM Hyman","year":"2017","unstructured":"Hyman JM, Holroyd CB, Seamans JK (2017) A novel neural prediction error found in anterior cingulate cortex ensembles. Neuron 95(2):447-456.e3","journal-title":"Neuron"},{"issue":"10","key":"8855_CR21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/nn.2921","volume":"14","author":"WH Alexander","year":"2011","unstructured":"Alexander WH, Brown JW (2011) Medial prefrontal cortex as an action-outcome predictor. Nat Neurosci 14(10):1338\u20131344","journal-title":"Nat Neurosci"},{"key":"8855_CR22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fnins.2018.00569","volume":"12","author":"Q Lin","year":"2018","unstructured":"Lin Q et al (2018) Influence of individual differences in fMRI-based pain prediction models on between-individual prediction performance. Front Neurosci 12:569","journal-title":"Front Neurosci"},{"issue":"9","key":"8855_CR23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpain.2017.03.008","volume":"18","author":"DA Seminowicz","year":"2017","unstructured":"Seminowicz DA, Moayedi M (2017) The dorsolateral prefrontal cortex in acute and chronic pain. J Pain 18(9):1027\u20131035","journal-title":"J Pain"},{"issue":"18","key":"8855_CR24","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1523\/JNEUROSCI.1954-15.2016","volume":"36","author":"A-K Br\u00e4scher","year":"2016","unstructured":"Br\u00e4scher A-K et al (2016) Different brain circuitries mediating controllable and uncontrollable pain. J Neurosci 36(18):5013\u20135025","journal-title":"J Neurosci"},{"key":"8855_CR25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s12035-018-1130-9","volume":"56","author":"W-Y Ong","year":"2019","unstructured":"Ong W-Y, Stohler CS, Herr DR (2019) Role of the prefrontal cortex in pain processing. Mol Neurobiol 56:1137\u20131166","journal-title":"Mol Neurobiol"},{"issue":"2","key":"8855_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pneurobio.2008.09.018","volume":"87","author":"AV Apkarian","year":"2009","unstructured":"Apkarian AV, Baliki MN, Geha PY (2009) Towards a theory of chronic pain. Prog Neurobiol 87(2):81\u201397","journal-title":"Prog Neurobiol"},{"issue":"1","key":"8855_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.82.4","volume":"82","author":"Y Hara","year":"2015","unstructured":"Hara Y (2015) Brain plasticity and rehabilitation in stroke patients. J Nippon Med Sch 82(1):4\u201313","journal-title":"J Nippon Med Sch"},{"issue":"8","key":"8855_CR28","first-page":"1390","volume":"39","author":"H Lv","year":"2018","unstructured":"Lv H et al (2018) Resting-state functional MRI: everything that nonexperts have always wanted to know. AJNR Am J Neuroradiol 39(8):1390\u20131399","journal-title":"AJNR Am J Neuroradiol"},{"key":"8855_CR29","first-page":"32","volume":"2","author":"MW Voss","year":"2010","unstructured":"Voss MW et al (2010) Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci 2:32","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"8855_CR30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/02701367.1992.10607557","volume":"63","author":"BH Marcus","year":"1992","unstructured":"Marcus BH et al (1992) Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 63(1):60\u201366","journal-title":"Res Q Exerc Sport"},{"issue":"8","key":"8855_CR31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ et al (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135\u20131139","journal-title":"Eur J Cancer"},{"key":"8855_CR32","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1007\/s00520-019-04771-8","volume":"27","author":"F Yeo","year":"2019","unstructured":"Yeo F et al (2019) Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy. Support Care Cancer 27:4753\u20134762","journal-title":"Support Care Cancer"},{"key":"8855_CR33","unstructured":"Rebok GW (2016) Selecting control groups: to what should we compare behavioral interventions. Behavioral intervention research: designing, evaluating, and implementing, pp 139\u2013159"},{"issue":"2","key":"8855_CR34","doi-asserted-by":"crossref","first-page":"djw206","DOI":"10.1093\/jnci\/djw206","volume":"109","author":"H Greenlee","year":"2017","unstructured":"Greenlee H et al (2017) BMI, Lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. J Natl Cancer Inst 109(2):djw206","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"8855_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29(3):162\u2013173","journal-title":"Comput Biomed Res"},{"issue":"2","key":"8855_CR36","first-page":"179","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis: I. Segment Surf Reconstruction Neuroimage 9(2):179\u2013194","journal-title":"Segment Surf Reconstruction Neuroimage"},{"issue":"9","key":"8855_CR37","doi-asserted-by":"crossref","first-page":"e106133","DOI":"10.1371\/journal.pone.0106133","volume":"9","author":"MN Baliki","year":"2014","unstructured":"Baliki MN et al (2014) Functional reorganization of the default mode network across chronic pain conditions. PLoS ONE 9(9):e106133","journal-title":"PLoS ONE"},{"key":"8855_CR38","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s00429-015-1161-1","volume":"221","author":"KS Hemington","year":"2016","unstructured":"Hemington KS et al (2016) Abnormal cross-network functional connectivity in chronic pain and its association with clinical symptoms. Brain Struct Funct 221:4203\u20134219","journal-title":"Brain Struct Funct"},{"key":"8855_CR39","doi-asserted-by":"publisher","unstructured":"Brownson-Smith R et al (2023) Effect of exercise before and\/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis. J Cancer Surviv 1\u201319. https:\/\/doi.org\/10.1007\/s11764-023-01450-w","DOI":"10.1007\/s11764-023-01450-w"},{"issue":"1","key":"8855_CR40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bja.2022.09.026","volume":"130","author":"M Seretny","year":"2023","unstructured":"Seretny M et al (2023) Neuroimaging reveals a potential brain-based pre-existing mechanism that confers vulnerability to development of chronic painful chemotherapy-induced peripheral neuropathy. Br J Anaesth 130(1):83\u201393","journal-title":"Br J Anaesth"},{"issue":"2","key":"8855_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10549-021-06304-6","volume":"189","author":"IR Kleckner","year":"2021","unstructured":"Kleckner IR et al (2021) Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy. Breast Cancer Res Treat 189(2):521\u2013532","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"8855_CR42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00520-023-07734-2","volume":"31","author":"S Stoller","year":"2023","unstructured":"Stoller S et al (2023) Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer 31(5):293","journal-title":"Support Care Cancer"},{"issue":"9","key":"8855_CR43","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/bjc.2014.466","volume":"111","author":"KS Courneya","year":"2014","unstructured":"Courneya KS et al (2014) Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy. Br J Cancer 111(9):1718\u20131725","journal-title":"Br J Cancer"},{"issue":"18","key":"8855_CR44","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.2015.10858","volume":"314","author":"TM Eijsvogels","year":"2015","unstructured":"Eijsvogels TM, Thompson PD (2015) Exercise is medicine: at any dose? JAMA 314(18):1915\u20131916","journal-title":"JAMA"},{"issue":"1","key":"8855_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.1090","volume":"5","author":"MS Corbett","year":"2014","unstructured":"Corbett MS, Higgins JP, Woolacott NF (2014) Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Res Syn Meth 5(1):79\u201385","journal-title":"Res Syn Meth"},{"issue":"1","key":"8855_CR46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14737175.2022.2018300","volume":"22","author":"SB Park","year":"2022","unstructured":"Park SB et al (2022) Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: systematic review and consensus expert opinion. Expert Rev Neurother 22(1):65\u201376","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"8855_CR47","first-page":"1390","volume":"39","author":"H Lv","year":"2018","unstructured":"Lv H et al (2018) Resting-state functional MRI: everything that nonexperts have always wanted to know. Am J Neuroradiol 39(8):1390\u20131399","journal-title":"Am J Neuroradiol"},{"key":"8855_CR48","unstructured":"Chung KH, Wagenknecht AW, Kleckner AS, Loh KP, Lin PJ, Ryan AS, Dorsey SG, Zhu S, Rosenblatt PY, Mustian KM, Kleckner IR (in press) High frequency sampling of patient chemotherapy symptoms to predict daily exercise behavior during a home-based exercise intervention: a feasibility study.\u00a0Oncol Nurs Forum"},{"issue":"1","key":"8855_CR49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0272684X19857427","volume":"40","author":"M Asare","year":"2019","unstructured":"Asare M et al (2019) Assessing physical activity behavior of cancer survivors by race and social determinants of health. Int Q Community Health Educ 40(1):7\u201316","journal-title":"Int Q Community Health Educ"},{"issue":"1","key":"8855_CR50","first-page":"28","volume":"14","author":"IR Kleckner","year":"2018","unstructured":"Kleckner IR et al (2018) Exercise for toxicity management in cancer\u2014a narrative review. Oncology Hematol Rev 14(1):28","journal-title":"Oncology Hematol Rev"},{"issue":"10","key":"8855_CR51","doi-asserted-by":"crossref","first-page":"10236","DOI":"10.21037\/apm-21-1432","volume":"10","author":"J-H Park","year":"2021","unstructured":"Park J-H et al (2021) Resistance and aerobic exercise intervention during chemotherapy in patients with metastatic cancer: a pilot study in South Korea. Ann Palliat Med 10(10):10236\u201310243","journal-title":"Ann Palliat Med"},{"key":"8855_CR52","doi-asserted-by":"crossref","first-page":"153473542093845","DOI":"10.1177\/1534735420938458","volume":"19","author":"G Piringer","year":"2020","unstructured":"Piringer G et al (2020) Influence of a structured exercise training on patients reported quality of life in colorectal cancer patients after adjuvant chemotherapy: a pilot study. Integr Cancer Ther 19:1534735420938458","journal-title":"Integr Cancer Ther"},{"issue":"11","key":"8855_CR53","doi-asserted-by":"crossref","first-page":"e14919","DOI":"10.14814\/phy2.14919","volume":"9","author":"EC Toffoli","year":"2021","unstructured":"Toffoli EC et al (2021) Effects of physical exercise on natural killer cell activity during (neo) adjuvant chemotherapy: a randomized pilot study. Physiol Rep 9(11):e14919","journal-title":"Physiol Rep"},{"key":"8855_CR54","unstructured":"Manuweera T, Karunakaran K, Baechler C, Rosales J, Kleckner AS, Rosenblatt P, Ciner A, Kleckner IR (Under review) Barriers and facilitators for participation in brain magnetic resonance imaging (MRI) scans in cancer research: a feasibility and acceptability analysis. Supportive Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08855-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:23:13Z","timestamp":1729297393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08855-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8855"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08855-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4022351\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The questionnaire and methodology for this study were approved by the Human Research Ethics committee of the University of Rochester Medical Center (RSRB 66046).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Although we do not believe there are any conflicts of interest, in full disclosure, here are the funding sources for this work and any *potential* conflicts of interest: This work was supported by the NCI (UG1CA189961 to KMM and Gary Morrow, R25CA102618 to Gary Morrow, and K07CA221931 to IRK). Resistance bands were generously donated by TheraBand. The authors also acknowledge training that contributed to this manuscript from the TREC Training Workshop (R25CA203650; PI: Melinda Irwin) and support with study logistics and accruals from the Clinical and Translational Science Institute grant support (UL1 TR002001 from the National Institutes of Health [NIH]). This publication was supported by funds from the Maryland Department of Health\u2019s Cigarette Restitution Fund, no. CH-649-CRF (to support AK and IRK). In the last 36 months, JSG received grant funding from the NIH and consulting income from Algo Therapeutix, Eikonizo, and GW Pharma; she also owns vesting shares in Eisana Corp.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}